Conformation of Factor VIIa Stabilized by a Labile Disulfide Bond (Cys-310–Cys-329) in the Protease Domain Is Essential for Interaction with Tissue Factor*

Unlike other trypsin-type serine proteases, zymogento-enzyme transition of conformation of factor VII apparently requires not only conversion of the zymogen to active form factor VIIa (VIIa) but also interaction of VIIa with tissue factor (TF). To determine the region of interaction that correlates with maturation of the VIIa active site, we modified intramolecular disulfide bonds in VIIa and examined the interaction of the modified VIIa with soluble TF (sTF). We found that partial reduction andS-carboxamidomethylation of disulfide bonds in VIIa led to losses of amidolytic activity and the binding ability to sTF. To determine the sites of modification that associate with the loss of functions, partially S-carboxamidomethylated VIIa was separated on a column of immobilized sTF. Each of the sTF-bound and sTF-unbound fractions and native VIIa was then digested by trypsin, and the digest was analyzed by reversed-phase high performance liquid chromatography. We found that reduction andS-carboxamidomethylation of a disulfide bond between Cys-310 and Cys-329 in the protease domain of VIIa led to loss of the binding ability with sTF, and the modification of a disulfide bond between Cys-340 and Cys-368 of VIIa led to loss of the amidolytic activity. In the three-dimensional structures of trypsinogen and trypsin, the disulfide bonds corresponding to Cys-340–Cys-368 and Cys-310–Cys-329 of VIIa are, respectively, in and adjacent to the activation domain, which has flexible conformation in trypsinogen but not in trypsin. Furthermore, the crystal structure of human VIIa·TF complex indicates that the region next to Cys-310–Cys-329 is in contact with sTF. We speculate that a regional flexibility, reflected by the labile nature of disulfide bonds of Cys-310–Cys-329 and Cys-340–Cys-368 in the protease domain, contributes to the inability of VIIa to attain the active conformation. Interaction of TF with this flexible region may stabilize the structure in a conformation similar to that of the active state of VIIa.

[1]  É. Várallyay,et al.  The role of disulfide bond C191-C220 in trypsin and chymotrypsin. , 1997, Biochemical and biophysical research communications.

[2]  W. Ruf,et al.  Identification of surface residues mediating tissue factor binding and catalytic function of the serine protease factor VIIa. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[3]  D. Bharadwaj,et al.  Factor VII Central , 1996, The Journal of Biological Chemistry.

[4]  S. Iwanaga,et al.  Molecular Mechanism of Tissue Factor-mediated Acceleration of Factor VIIa Activity* , 1996, The Journal of Biological Chemistry.

[5]  David W. Banner,et al.  The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor , 1996, Nature.

[6]  D. Stafford,et al.  The roles of factor VII's structural domains in tissue factor binding. , 1995, Biochemistry.

[7]  J. McVey,et al.  Surface plasmon resonance studies of the interaction between factor VII and tissue factor. Demonstration of defective tissue factor binding in a variant FVII molecule (FVII-R79Q). , 1994, Biochemistry.

[8]  S. Iwanaga,et al.  Identification of regions of bovine factor VII essential for binding to tissue factor. , 1994, The Journal of biological chemistry.

[9]  H. Saito,et al.  Impaired human tissue factor-mediated activity in blood clotting factor VIINagoya (Arg304-->Trp). Evidence that a region in the catalytic domain of factor VII is important for the association with tissue factor. , 1994, The Journal of biological chemistry.

[10]  A. Wacey,et al.  Molecular defects in CRM+ factor VII deficiencies: modelling of missense mutations in the catalytic domain of FVII , 1994, British journal of haematology.

[11]  D. Branam,et al.  Importance of Substrate Composition, pH and Other Variables on Tissue Factor Enhancement of Factor Vlla Activity , 1993, Thrombosis and Haemostasis.

[12]  W. Kisiel,et al.  Isolation and characterization of proteolytic fragments of human factor VIIa which inhibit the tissue factor-enhanced amidolytic activity of factor VIIa. , 1993, The Journal of biological chemistry.

[13]  Y. Nemerson,et al.  Human factor VIIa and its complex with soluble tissue factor: evaluation of asymmetry and conformational dynamics by ultracentrifugation and fluorescence anisotropy decay methods. , 1993, Biochemistry.

[14]  P. Comp,et al.  Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation , 1993 .

[15]  K. Mann,et al.  Complex-dependent inhibition of factor VIIa by antithrombin III and heparin. , 1993, The Journal of biological chemistry.

[16]  J. Birktoft,et al.  Identification of a calcium binding site in the protease domain of human blood coagulation factor VII: evidence for its role in factor VII-tissue factor interaction. , 1993, Biochemistry.

[17]  T. Miyata,et al.  Expression of human soluble tissue factor in yeast and enzymatic properties of its complex with factor VIIa. , 1992, The Journal of biological chemistry.

[18]  S. Iwanaga,et al.  Tissue factor potentiates the factor VIIa-catalyzed hydrolysis of an ester substrate. , 1992, The Journal of biological chemistry.

[19]  K. Mann,et al.  The evaluation of complex-dependent alterations in human factor VIIa. , 1992, The Journal of biological chemistry.

[20]  S. Iwanaga,et al.  cDNA and amino acid sequences of bovine tissue factor. , 1991, Biochemical and biophysical research communications.

[21]  K Fujikawa,et al.  The coagulation cascade: initiation, maintenance, and regulation. , 1991, Biochemistry.

[22]  K. Smith,et al.  Localization of the human tissue factor recognition determinant of human factor VIIa. , 1991, The Journal of biological chemistry.

[23]  T S Edgington,et al.  Characterization of factor VII association with tissue factor in solution. High and low affinity calcium binding sites in factor VII contribute to functionally distinct interactions. , 1991, The Journal of biological chemistry.

[24]  N. Mackman,et al.  The Structural Biology of Expression and Function of Tissue Factor , 1991, Thrombosis and Haemostasis.

[25]  G. Miller,et al.  Purification and characterization of factor VII 304-Gln: a variant molecule with reduced activity isolated from a clinically unaffected male. , 1991, Blood.

[26]  D. Blumenthal,et al.  Identification of molecular sites on factor VII which mediate its assembly and function in the extrinsic pathway activation complex. , 1991, The Journal of biological chemistry.

[27]  K. Norris,et al.  Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions. , 1990, The Journal of biological chemistry.

[28]  S. Kawabata,et al.  Monoclonal antibody (VII-M31) to bovine factor VII: a specific epitope in the gamma-carboxyglutamic acid domain. , 1990, Journal of biochemistry.

[29]  W. Kisiel,et al.  The importance of residues 195-206 of human blood clotting factor VII in the interaction of factor VII with tissue factor. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[30]  W. Kisiel,et al.  The gamma-carboxyglutamic acid domain of human factor VIIa is essential for its interaction with cell surface tissue factor. , 1990, The Journal of biological chemistry.

[31]  K. Nakagawa,et al.  Bovine factor VII. Its purification and complete amino acid sequence. , 1988, The Journal of biological chemistry.

[32]  Y. Nemerson,et al.  Kinetics of the activation of bovine coagulation factor X by components of the extrinsic pathway. Kinetic behavior of two-chain factor VII in the presence and absence of tissue factor. , 1977, The Journal of biological chemistry.

[33]  R. Huber,et al.  Crystal structure of bovine trypsinogen at 1-8 A resolution. I. Data collection, application of patterson search techniques and preliminary structural interpretation. , 1976, Journal of molecular biology.

[34]  S. Moore,et al.  Automatic recording apparatus for use in the chromatography of amino acids. , 1958, Federation proceedings.

[35]  Y. Nemerson Tissue factor and hemostasis. , 1988, Blood.